The taxpayer-backed Cancer Prevention & Research Institute of Texas is moving downstream from its initial focus on basic research in oncology. This month, the institute announced its latest round of grants--this time focusing on both translational- and commercial-stage research, the latter of which includes recruiting companies to relocate to Texas.